New Jersey S 1714: Prohibits pre-approval or precertification of cancer treatments, tests, procedures and prescription drugs covered under health benefits or prescription drug benefits plans.

Status: Introduced in the Senate, Referred to Senate Commerce Committee (as of 2020-02-10)

State: New Jersey · Session: 219 · Bill: S 1714

Subjects: HEALTH INSUR, PHARMACEUTIC

Sponsors: Bucco, Anthony M.

View New Jersey S 1714 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.